LONDON (Reuters) - British biotech group Silence Therapeutics has raised 38.9 million pounds ($58.2 million) by selling two tranches of new shares at 240 pence each to develop its genetic medicine platform.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment